Your browser doesn't support javascript.
loading
Neuroprotective validation of pectin in T2DM-induced allodynia and hyperalgesia in diabetic peripheral neuropathic pain.
Srivastava, Rajnish; Tripathi, Laxmi; Swain, Sudhansu Ranjan; Singh, Jagan.
Afiliação
  • Srivastava R; Moradabad Educational Trust Group of Institutions Faculty of Pharmacy, Moradabad, India.
  • Tripathi L; Agra Public Pharmacy college, Agra, India.
  • Swain SR; Moradabad Educational Trust Group of Institutions Faculty of Pharmacy, Moradabad, India.
  • Singh J; Moradabad Educational Trust Group of Institutions Faculty of Pharmacy, Moradabad, India.
Arch Physiol Biochem ; 129(4): 901-912, 2023 Dec.
Article em En | MEDLINE | ID: mdl-33618606
ABSTRACT

AIM:

To validate neuroprotective effect of pectin against neuropathic pain in diabetic rodents. MATERIAL AND

METHOD:

Pectin was isolated and characterised from different sources to validate its neuroprotective effect against T2DM associated neuropathic pain. The antioxidant activity of pectins was done by the DPPH method. Type-2 diabetes mellitus (T2DM) was induced in Wistar albino rats by high-fat diet and high-fat emulsion feeding for 2 weeks followed by a single i.p. of Sterptozotocin in 3rd week. The animals were grouped as positive control and Citrus sinensis (L.) Osbeck peel pectin (CSL-OP) as test group and treated for the next 4 weeks. Body weight and blood glucose were measured up to 8 weeks; however, behavioural assessment was done at the end of 5th to 8th week.

RESULT:

CSL-OP restored the reduced body weight and elevated blood glucose with increased pain threshold and improved walking performance.

CONCLUSION:

CSL-OP prevented progression of early diabetic neuropathy with anti-oxidant activity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Fármacos Neuroprotetores / Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Neuropatias Diabéticas / Neuralgia Limite: Animals Idioma: En Revista: Arch Physiol Biochem Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Fármacos Neuroprotetores / Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Neuropatias Diabéticas / Neuralgia Limite: Animals Idioma: En Revista: Arch Physiol Biochem Ano de publicação: 2023 Tipo de documento: Article